within Pharmacolibrary.Drugs.ATC.M;

model M05BX05
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.73,
    Cl             = 0.004833333333333333,
    adminDuration  = 600,
    adminMass      = 0.001,
    adminCount     = 1,
    Vd             = 0.008,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Burosumab is a fully human monoclonal antibody targeting fibroblast growth factor 23 (FGF23). It is used for the treatment of X-linked hypophosphatemia (XLH) in adults and children 1 year of age and older. It is an approved drug for this indication in the US and EU.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for adult and pediatric patients with X-linked hypophosphatemia following subcutaneous administration. Based on population PK analysis.</p><h4>References</h4><ol><li><p>Lamb, YN (2018). Burosumab: First Global Approval. <i>Drugs</i> 78(6) 707–714. DOI:<a href=&quot;https://doi.org/10.1007/s40265-018-0905-7&quot;>10.1007/s40265-018-0905-7</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29679282/&quot;>https://pubmed.ncbi.nlm.nih.gov/29679282</a></p></li><li><p>Lee, SK, et al., &amp; Shi, J (2022). Population Pharmacokinetics and Pharmacodynamics of Burosumab in Adult and Pediatric Patients With X-linked Hypophosphatemia. <i>Journal of clinical pharmacology</i> 62(1) 87–98. DOI:<a href=&quot;https://doi.org/10.1002/jcph.1950&quot;>10.1002/jcph.1950</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34352114/&quot;>https://pubmed.ncbi.nlm.nih.gov/34352114</a></p></li><li><p>Zhang, X, et al., &amp; Peacock, M (2016). Pharmacokinetics and pharmacodynamics of a human monoclonal anti-FGF23 antibody (KRN23) in the first multiple ascending-dose trial treating adults with X-linked hypophosphatemia. <i>Journal of clinical pharmacology</i> 56(2) 176–185. DOI:<a href=&quot;https://doi.org/10.1002/jcph.570&quot;>10.1002/jcph.570</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26073451/&quot;>https://pubmed.ncbi.nlm.nih.gov/26073451</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end M05BX05;
